Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Insurance topic
No spam. Unsubscribe anytime.
Committee advances HB300 to eliminate copays for supplemental breast imaging
Summary
HB300, which would remove co-pays and extra fees for additional medically necessary breast diagnostic imaging following a screening mammogram, was amended for technical language and to delay effectiveness to Jan. 1, 2027, and was given a favorable report by the committee.
The committee gave HB300 a favorable report after adopting two friendly amendments that clarified technical language and moved the bills effective date to Jan. 1, 2027.
Sponsor (identified in the record as the bills sponsor, speaker 4) said HB300 eliminates the out-of-pocket cost for second or third diagnostic breast imaging that follows a screening mammogram. The sponsor recounted a recent personal experience to underscore the importance of timely follow-up care, telling the committee she received a second mammogram and an ultrasound within hours and that quick diagnosis made a difference. "This removes the financial barriers when it is medically necessary for the breast cancer screening and diagnostic imaging," the sponsor said.
Representative Blackshear offered a technical amendment to better align the bills wording with National Comprehensive Cancer Network guidance for medically necessary supplemental breast examinations; the committee adopted that amendment by voice vote. A second amendment moved the effective date to Jan. 1, 2027 to allow health-plan and provider programming time; members said the change aligns implementation with calendar-year business practices.
Representative Blackshear moved and Representative Easterbrook seconded the favorable report as amended; the committee approved the bill by voice vote.
Next steps: HB300 will move forward in the legislative process with the committees recommended amendments.
